News & Updates

Show Multimedia Only
Hydroxychloroquine protects SLE patients against CV events

Hydroxychloroquine protects SLE patients against CV events

11 Sep 2024

Among patients with systemic lupus erythematosus (SLE), those who use of hydroxychloroquine are less likely to experience cardiovascular events, as reported in a study.

Hydroxychloroquine protects SLE patients against CV events

11 Sep 2024
Vitamin D deficiency tied to higher T2D risk

Vitamin D deficiency tied to higher T2D risk

09 Sep 2024

Increased serum concentration of 25(OH)D appears to contribute to a reduced risk of type 2 diabetes (T2D) across the glycaemic spectrum below the threshold for diabetes, reports a study. Improving the lipid profile may be partly responsible for the favourable association.

Vitamin D deficiency tied to higher T2D risk

09 Sep 2024